individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups
of the population could benefit most. In response to an urgent request from the UK Joint
Committee on Vaccination and Immunisation, we aimed to identify risk factors for severe
COVID-19 outcomes (ie, COVID-19-related hospitalisation or death) in individuals who had
completed their primary COVID-19 vaccination schedule and had received the first booster …